Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial ...Middle East

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety Disorder Phase 2 clinical trial on target to start by end of 2021 and expected to read out topline data by end of 2022 ADELAIDE, Australia, Sept....

Hence then, the article about bionomics prepares bnc210 for start of phase 2 acute treatment of social anxiety disorder trial was published today ( Monday 20/09/2021 - 01:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial )

Also on site :

• 'Love Island USA': Carl Defends Trinity After Recoupling Argument With Tierra
• Trump threatens Iran ‘will no longer exist’ for ceasefire violation
• Iran-US war live: Trump warns Iran ‘will ​no longer exist’ as Tehran strikes US bases in Bahrain and Kuwait